35 studies found for:    " March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (35 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center
Condition: HIV Seropositivity
Interventions: Drug: Placebo;   Drug: Rouvastatin calcium
2 Completed Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts
Condition: QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen
3 Recruiting Metabolomics Fingerprinting and Metabolic Dynamis After HIV Infection
Condition: HIV
4 Active, not recruiting Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Condition: HIV
Interventions: Behavioral: Social Network Intervention;   Behavioral: Counsel, Test, and Treat
5 Completed
Has Results
Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools
Condition: HIV Infection
6 Terminated
Has Results
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Condition: Human Immunodeficiency Virus
7 Active, not recruiting Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Conditions: HIV;   HIV Infections
Intervention: Drug: E/C/F/TAF
8 Active, not recruiting Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: EFV/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: COBI
9 Recruiting Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Conditions: Adult Solid Neoplasm;   Advanced Malignant Neoplasm;   HIV Infection;   Metastatic Malignant Neoplasm;   Recurrent Malignant Neoplasm;   Solid Neoplasm;   Unresectable Malignant Neoplasm
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
10 Completed Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
Conditions: Influenza;   Human Immunodeficiency Virus
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
11 Completed Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels
Conditions: HIV;   Hypercholesterolaemia
Interventions: Drug: Switch ritonavir-boosted PI;   Drug: Continue Ritonavir-boosted PI+Rosuvastatin
12 Completed UCLA-Amity Parolee Health Promotion Study
Conditions: Hepatitis B;   Hepatitis C;   HIV;   Drug Addiction
Interventions: Behavioral: Parolee Comprehensive Care + Phone Coach;   Behavioral: Parolee Brief HBV Program + Phone Coach;   Behavioral: Usual Care Group
13 Active, not recruiting Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services
Condition: HIV
Intervention: Behavioral: Conditional cash transfer
14 Withdrawn SCOPE: Strategies to Combine PrEP With Prevention Efforts
Condition: HIV
Intervention: Drug: Once daily Truvada®
15 Enrolling by invitation Transmission Reduction Intervention Project
Condition: HIV
Interventions: Other: Assays;   Other: HIV medical care;   Other: Social network and venue tracing;   Other: Community alerts;   Other: Community education;   Behavioral: HIV counseling
16 Enrolling by invitation Social Network Intervention to Engage Out-of-Care PLH Into Treatment
Conditions: HIV;   AIDS
Interventions: Behavioral: Social Network Leader Endorsement;   Behavioral: HIV Counseling
17 Recruiting HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women
Condition: HIV
Intervention: Drug: Atripla or Stribild
18 Withdrawn Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
Conditions: Influenza, Human;   HIV;   Malaria;   Tetanus;   Polio
Interventions: Biological: Quadrivalent Inactivated Influenza Vaccine (QIV);   Biological: Inactivated Polio Vaccine;   Biological: Double Dose QIV
19 Active, not recruiting Immune Enhancement for Immunological Non-responders to ART
Condition: HIV
Intervention: Dietary Supplement: Zinc and SAMe
20 Enrolling by invitation The "START" (a Streamlined ART Initiation Strategy) Study
Condition: HIV
Intervention: Behavioral: START

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years